Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07425392 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Prior Pneumococcal Vaccination

StatusActive, Not Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv5
  2. Trial status changed: Recruiting → Active, Not Recruiting
    • Enrollment target: estimated 720 to confirmed 752
    • Site details revised at 30 of 30 sites
    v4
  3. Site details revised at 1 of 30 sitesv3
  4. Site details revised at 3 of 30 sitesv2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study will evaluate the safety, tolerability, and immunogenicity of VAX-31 in adults ≥50 years of age.
Trial Details
NCT Number NCT07425392
Lead Sponsor Vaxcyte, Inc.
Conditions
(from sponsor)		 Pneumococcal Vaccines
Related terms Pneumococcal Infections, Pneumonia
Enrollment 752 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov